Lakefront Biotherapeutics
LKFT
30.00
+0.68
+2.32%
Lakefront Biotherapeutics
US · LKFT
#2803 by market cap
Listed 1970
30.00
+0.68
+2.32%
Live - 5344 symbols - heartbeat 98s ago
· 2026-10-08 08:46
Pre-market
29.43
-1.90%
After-hours
30.00
0.00%
Overnight
29.31
-2.30%
- Market cap
- 1.96B
- P/E (TTM)i
- 2.96
- P/Bi
- 0.54
- EPSi
- 5.45
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on LKFT?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 2 analysts
Buy
Avg price target
37.50 +25.0%
Price target rangecurrent 30.00
Low30.00
Avg37.50
High45.00
Buy 50%
Hold 50%
Sell 0%
Recent ratings (4)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-23 | RBC Capital | -- | BUY | 45.00 |
| 2026-08-03 | Morgan Stanley | -- | HOLD | 30.00 |
| 2026-05-13 | RBC Capital | -- | HOLD | 28.00 |
| 2026-03-16 | Morgan Stanley | -- | SELL | 22.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: RBC Capital moved from Hold to Buy on 2026-09-23.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-23 | RBC Capital | HOLD → BUY | 45.00 |
| 2026-08-03 | Morgan Stanley | SELL → HOLD | 30.00 |
Quote time 2026-10-08 08:46:44 · For reference only, not investment advice and not tailored to your situation.